<?xml version="1.0" encoding="UTF-8"?>
<p>Molecular docking simulation studies were performed using molecular operating environment (MOE
 <sup>Â®</sup>) version 2015.10. The vascular endothelial growth factor receptor (VEGFR) (PDB 4ASD) was used as a receptor for the docking study and 
 <bold>Sorafenib</bold> as a reference drug.
</p>
